Paal Brunsvig
- Oncology top 5%
- Lung Cancer Research Studies 13
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 6
-
- Lung Cancer Treatments and Mutations 15
- Lung Cancer Diagnosis and Treatment 8
- Immunology top 10%
- Immunotherapy and Immune Responses 9
- Biotechnology top 5%
- Cancer Research and Treatments 10
- Otorhinolaryngology top 10%
-
- Neuroendocrine Tumor Research Advances 6
- Co-authors
- Steinar AamdalStein SundstrømRoy M. BremnesUlf AasebøGustav GaudernackStein KaasaMona MøllerØystein Fløtten
- Journals
- Journal of Clinical Oncology (12 papers)JNCI Journal of the National Cancer Institute (1 paper)Cancer Research (2 papers)
- Partner nations
- NorwayUnited KingdomUnited States
In The Last Decade
Paal Brunsvig
46 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 90
- Oncology 787
- Pulmonary and Respiratory Medicine 592
- Immunology 380
- Biotechnology 121
- Otorhinolaryngology 52
Countries citing papers authored by Paal Brunsvig
This map shows the geographic impact of Paal Brunsvig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paal Brunsvig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paal Brunsvig more than expected).
Fields of papers citing papers by Paal Brunsvig
This network shows the impact of papers produced by Paal Brunsvig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paal Brunsvig. The network helps show where Paal Brunsvig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paal Brunsvig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 35 | |
| 2 | 2018 | 1 | |
| 3 | 2017 | 79 | |
| 4 | 2015 | 28 | |
| 5 | 2011 | 131 | |
| 6 | 2010 | 18 | |
| 7 | 2009 | 7 | |
| 8 | 2008 | 30 | |
| 9 | 2008 | 12 | |
| 10 | 2008 | 26 | |
| 11 | 2008 | 17 | |
| 12 | 2007 | 1 | |
| 13 | 2007 | 60 | |
| 14 | 2007 | 2 | |
| 15 | 2007 | 34 | |
| 16 | 2006 | 59 | |
| 17 | 2006 | 196 | |
| 18 | 2006 | 16 | |
| 19 | 2005 | 12 | |
| 20 | 2005 | 23 |
About Paal Brunsvig
Paal Brunsvig is a scholar working on Oncology, Biotechnology and Otorhinolaryngology, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (13 papers), Cancer Research and Treatments (10 papers), Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (9 papers), Lung Cancer Diagnosis and Treatment (8 papers), Neuroendocrine Tumor Research Advances (6 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Oncology (787 citations), Pulmonary and Respiratory Medicine (592 citations) and Immunology (380 citations). Paal Brunsvig has collaborated with scholars based in Norway, United Kingdom and United States. Frequent co-authors include Steinar Aamdal, Stein Sundstrøm, Roy M. Bremnes, Ulf Aasebø, Gustav Gaudernack, Stein Kaasa, Mona Møller, Øystein Fløtten, Christian von Plessen and Bjørn Henning Grønberg. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.